Related Experiment Videos
The National Cancer Institute: cancer drug discovery and development program.
M R Grever1, S A Schepartz, B A Chabner
1Director, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD 20892.
Seminars in Oncology
|December 1, 1992
Summary
The National Cancer Institute (NCI) is advancing novel cancer therapies through revised screening and molecular drug design. This research highlights ongoing efforts to discover effective treatments for cancer patients, addressing both potential and challenges.
Area of Science:
- Oncology
- Pharmacology
- Drug Discovery
Background:
- Developing new cancer treatments is crucial for patient care.
- The National Cancer Institute (NCI) plays a key role in cancer drug development.
- Understanding the complex processes involved is essential.
Purpose of the Study:
- To provide insight into the National Cancer Institute's (NCI) efforts in discovering novel therapeutic products for malignancy.
- To update on the NCI's revised cancer screening process.
- To discuss the molecular approach to cancer drug design.
Main Methods:
- Review of NCI's ongoing drug discovery and development processes.
- Summary of new agents entering clinical investigation.
- Discussion of advantages and challenges in molecular cancer drug design.
Main Results:
- The NCI is actively pursuing new therapeutic agents for cancer treatment.
- A revised cancer screening process is being implemented.
- Molecular approaches offer significant potential but also present challenges in drug design.
Conclusions:
- There is a critical need for effective new cancer therapies.
- The NCI's efforts are vital in the complex process of drug discovery.
- Collaboration and diverse strategies are important for advancing cancer treatment.